C07D 285/20
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D285/20 (Condensed with carbocyclic rings or ring systems) appears on 139 US grants and 115 published applications in this corpus.
Search patents in C07D- Granted patents
- 139
- Published applications
- 115
- Assignees
- 76
- Inventors
- 402
- Latest grant
- 23 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 3 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 5 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 4 | 5 |
| 2004 | 1 | 4 |
| 2005 | 4 | 9 |
| 2006 | 4 | 11 |
| 2007 | 8 | 3 |
| 2008 | 3 | 7 |
| 2009 | 7 | 5 |
| 2010 | 5 | 8 |
| 2011 | 2 | 2 |
| 2012 | 4 | 4 |
| 2013 | 5 | 4 |
| 2014 | 3 | 5 |
| 2015 | 1 | 4 |
| 2016 | 4 | 6 |
| 2017 | 8 | 5 |
| 2018 | 4 | 5 |
| 2019 | 4 | 2 |
| 2020 | 1 | 4 |
| 2021 | 3 | 5 |
| 2022 | 2 | 3 |
| 2023 | 2 | 3 |
| 2024 | 4 | 4 |
| 2025 | 5 | 6 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Methods for treating subjects with Prader-Willi syndrome23 Sep 2025US 12,419,895 B1Essentialis, Inc.
- Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome1 Jul 2025US 12,343,348 B2Essentialis, Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution8 Apr 2025US 12,268,783 B2Theaprin Pharmaceuticals Inc.
- 3-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX211 Mar 2025US 12,247,015 B2Solent Therapeutics, LLC
- Therapeutics for the treatment of glaucoma28 Jan 2025US 12,209,140 B2Mayo Foundation for Medical Education and Research
- Novel atp-sensitive potassium channel potentiators, their preparation and use27 Nov 2025US 2025/0360142 A1Rhythm Pharmaceuticals, Inc.
- Methods for treating subjects with prader-willi syndrome18 Sep 2025US 2025/0288593 A1Essentialis, Inc.
- 3-amino-4h-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of mrgx218 Sep 2025US 2025/0289792 A1Solent Therapeutics, LLC
- Platform drug delivery system utilizing crystal engineering and theanine dissolution17 Jul 2025US 2025/0228778 A1Theaprin Pharmaceuticals Inc.
- Mrgprx2 modulators and related methods of treatment29 May 2025US 2025/0170141 A1Escient Pharmaceuticals, Inc.
Most cited
By later US patents
- Quinoline derivatives as PI3 kinase inhibitors178US 8,138,347 B2GlaxoSmithKline LLC · 2012
- Compositions and methods for inhibition of the JAK pathway88US 7,491,732 B2Rigel Pharmaceuticals, Inc. · 2009
- Substituted aminomethyltetralins and their heterocyclic analogues81US 5,137,901 ABayer Aktiengesellschaft · 1992
- Salts of potassium ATP channel openers and uses thereof69US 7,572,789 B2Essentialis, Inc. · 2009
- Benzo thiadiazine matrix metalloproteinase inhibitors40US 6,656,932 B2Warner-Lambert Company · 2003